Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
August 22, 2024
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads
Akash M Patel, Aarron Willingham, Alan C Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2013
Structure guided design of a series of sphingosine kinase (SphK) inhibitors
Darin J Gustin, Yihong Li, Matthew L Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2011
Discovery of triazine-benzimidazoles as selective inhibitors of mTOR
Emily A Peterson, Paul S Andrews, Xuhai Be, et al.
Journal of Medicinal Chemistry
|
July 25, 2022
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α
Victor W Mak, Akash M Patel, Rose Yen, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase
Victor J Cee, Alan C Cheng, Karina Romero, et al.
Scientific Reports
|
January 23, 2021
Discovery of a new class of integrin antibodies for fibrosis
Ji Zhang, Tao Wang, Ashmita Saigal, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors
Emily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Journal of Medicinal Chemistry
|
November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere
Gwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Scientific Reports
|
August 23, 2023
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants
Scott A Hollingsworth, Cameron L Noland, Karin Vroom, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
August 22, 2024
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads
Akash M Patel, Aarron Willingham, Alan C Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2013
Structure guided design of a series of sphingosine kinase (SphK) inhibitors
Darin J Gustin, Yihong Li, Matthew L Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2011
Discovery of triazine-benzimidazoles as selective inhibitors of mTOR
Emily A Peterson, Paul S Andrews, Xuhai Be, et al.
Journal of Medicinal Chemistry
|
July 25, 2022
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α
Victor W Mak, Akash M Patel, Rose Yen, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase
Victor J Cee, Alan C Cheng, Karina Romero, et al.
Scientific Reports
|
January 23, 2021
Discovery of a new class of integrin antibodies for fibrosis
Ji Zhang, Tao Wang, Ashmita Saigal, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors
Emily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Journal of Medicinal Chemistry
|
November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere
Gwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Scientific Reports
|
August 23, 2023
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants
Scott A Hollingsworth, Cameron L Noland, Karin Vroom, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Page
of 6